Pages that link to "Q37088083"
Jump to navigation
Jump to search
The following pages link to Delivering silence: advancements in developing siRNA therapeutics. (Q37088083):
Displaying 14 items.
- Microneedles As a Delivery System for Gene Therapy (Q26746026) (← links)
- Sequence determinants of innate immune activation by short interfering RNAs. (Q33486742) (← links)
- Minimal-length Synthetic shRNAs Formulated with Lipid Nanoparticles are Potent Inhibitors of Hepatitis C Virus IRES-linked Gene Expression in Mice (Q33637385) (← links)
- First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. (Q33730680) (← links)
- A status report on RNAi therapeutics (Q34013891) (← links)
- Specific Jak3 Downregulation in Lymphocytes Impairs γc Cytokine Signal Transduction and Alleviates Antigen-driven Inflammation In Vivo (Q36299372) (← links)
- Human macrophage and dendritic cell-specific silencing of high-mobility group protein B1 ameliorates sepsis in a humanized mouse model. (Q36485210) (← links)
- siRNA and the lung: research tool or therapeutic drug? (Q37166074) (← links)
- Maintaining the silence: reflections on long-term RNAi (Q37213586) (← links)
- RNAi Therapeutic Platforms for Lung Diseases (Q37277373) (← links)
- Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapies (Q38073028) (← links)
- Stability study of unmodified siRNA and relevance to clinical use. (Q39317131) (← links)
- In vivo quantification of formulated and chemically modified small interfering RNA by heating-in-Triton quantitative reverse transcription polymerase chain reaction (HIT qRT-PCR). (Q42426586) (← links)
- Tumor-targeted delivery of siRNA by non-viral vector: safe and effective cancer therapy (Q82758574) (← links)